Are pharmaceutical makers becoming outcomes companies? with AJ Ploszay, Ph.D. (GlaxoSmithKline) Brad Ansley (SPI Health)

from Business of Healthcare · host Business of Healthcare; Matthew Hanis

Digital is disrupting pharmaceutical companies at their very core: product development and commercial operations. We explore this with two leaders deep in the thick of transforming this key healthcare segment . . . 10% of the overall healthcare spend in the US . . . as digital innovation destroys and recreates the industry.

Episode metadata supplied by the publisher feed · Published May 29, 2018

Embed this episode

Attribution link and audio player

Ready to play

Are pharmaceutical makers becoming outcomes companies? with AJ Ploszay, Ph.D. (GlaxoSmithKline) Brad Ansley (SPI Health)

0:00 32:36

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Business of Healthcare?

This episode is 32 minutes long.

When was this Business of Healthcare episode published?

This episode was published on May 29, 2018.

Can I download this Business of Healthcare episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!